| Complement C5aR Inhibition – not recruiting |
 |
 |
 Share
Another complement factor under investigation is C5aR, which has been found localized in drusen and on the edges of geographic atrophy. Preclinical studies have suggested that blocking C5aR could be useful
in stopping wet macular degeneration. In development is an extended release formula that would be administered only twice a year. We are sure to hear more about the potential for this therapy. |
Search
Get News!
SIGN UP NOW
To receive the "AMD Update" and keep up-to-date with the latest research & treatment options:
For Email Newsletters you can trust